Bausch + Lomb Announces New Scientific Data, Educational Events at the European Society of Cataract and Refractive Surgery Annual Meeting

  • 35 data presentations and posters, including a Spotlight Presentation on the enVista Envy™ full visual range intraocular lens
  • Multiple events and demonstrations will enable surgeons to hear from top ophthalmologists and engage with the latest Bausch + Lomb technology

VAUGHAN, Ontario, Sept. 2, 2025 – Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the presentation of new scientific data and educational events at the European Society of Cataract and Refractive Surgery (ESCRS) annual meeting in Copenhagen, Denmark, Sept. 12–16.

Scientific posters and papers will highlight the results of studies evaluating Bausch + Lomb technologies including LuxLife™ and enVista Aspire™ premium intraocular lenses (IOLs), the ELIOS™ procedure for the treatment of glaucoma and new data on dry eye based on a multinational survey. Sponsored educational events will focus on these and other Bausch + Lomb products.

At the Bausch + Lomb exhibit booth (C2.025), the company will feature recent surgical innovations. Register here for product demonstrations, including the Fully Digital SeeLuma™ Visualization Platform and the OCTAVIUS customized corneal treatment.

The company is also a sponsor of the 30th anniversary of the first use of Femtosecond Lasers in ophthalmic surgery celebration, as well as iNovation® Day 2025, where Bausch + Lomb Chief Medical Officer and Executive Vice President of Research and Development Yehia Hashad will be on the “Managing Presbyopia: Keys to Sustainable Category Growth” panel. He will be joined by Bausch + Lomb Surgical President Luc Bonnefoy for a panel discussion titled “Executive Leadership Perspectives: Visions for the Next 5 Years.”

See below for a complete list of Bausch + Lomb events and scientific presentations.

Saturday, September 13, 2025

Lunchtime Symposium: Inspired by the Natural Wonder of the Northern Lights - A New Dawn in Ophthalmic Surgery Innovation

  • 13:00-14:00, Auditorium 10
  • Speakers: Dr. Cathleen McCabe, Prof. Suphi Taneri, Assoc. Prof. Christina Leydolt, Dr. Francesco Carones and Dr. Ana Miguel
  • Join a panel of experts as they discuss their experience with Bausch + Lomb technologies including the OCTAVIUS customized corneal treatment and transEpi PRK procedure with the Teneo M2; the enVista Aspire and LuxLife premium IOLs and the ELIOS procedure for the treatment of glaucoma.

A Spotlight on Dry Eye Disease in Ocular Surgery

  • 18:00-20:00, Scandic Spectrum Hotel, Copenhagen
  • Speakers: Dr. Elisabeth Messmer, Dr. Wassim Altroudi, Dr. Piotr Wozniak and Dr Lisa Nijm
  • Leading ophthalmologists will share their clinical experience of dry eye management in ocular surgery. Following the presentations, you will also have the opportunity to view our innovation stand and congress poster portfolio and engage in an open discussion and share best practices.
  • Please register here.

Sunday, September 14, 2025

IME Session: Modern Presbyopia Correction – Innovations in IOL Technology and Customized Patient Planning

  • 9:30-10:45; Room D4
  • Mr. Jonathan Yu from the United Kingdom will present a case study on the LuxLife IOL.

Lift off: Innovation Meets Inspiration 

  • 18:30-22:30, SMK National Gallery, Solvgade 48-50,1307 Indre By, Copenhagen (buses depart the congress center at 18:00)
  • Attendees can connect with a natural visual experience during this experience celebrating the wonder of the Northern Lights. Take advantage of this opportunity to network with peers and learn about the latest innovations from Bausch + Lomb.

Spotlight Abstract

  • “Safety and Performance of a Novel Full Visual Range Intraocular Lens: US Pivotal Clinical Study.”  McCabe C.

Paper Presentations

  • “Influence of Residual Astigmatism on Patient Satisfaction and Dysphotopsias After Implantation of a Novel Full Range of Vision IOL.” Muzychuk A.
  • “Clinical Outcomes of a Novel Full Range of Vision Intraocular Lens at 6- and 12-Months After Bilateral Implantation.” Castro FJ.
  • “Visual Outcomes and Depth of Focus from Ray Tracing Aberrometry in Small Aperture Optics Intraocular Lens in Eyes with Aberrated Corneas.” Klyce S.
  • “Early Outcomes of Transepithelial Photorefractive Keratectomy (tPRK) with PROSCAN Aspheric Treatment Compared with OCTAVIUS Topography-Optimized Treatment.” Tagal J.
  • “Correction of High Myopia with Laser in Situ Keratomileusis Performed Using an Advanced Excimer Laser System with an Aspheric Ablation Algorithm.” Stonecipher K.
  • “Real-World Outcomes of LASIK Using a Novel FDA-Approved Advanced Excimer Laser with Aspheric Ablation Profile for the Correction of Myopia and Myopic Astigmatism.” Waring G.
  • “Combined Phaco-Excimer Trabeculostomies: Up to 24 Month Follow-Up.” Grise-Dulac A.
  • “Systematic Review and Meta-Analysis of the Long-Term Efficacy and Safety of Excimer Laser Trabeculostomy.” Gazard G.

Presented Posters

  • “Dry Eye Symptoms, Severity, Treatment and Unmet Needs: An Analysis of the United States and a Multinational Snapshot.” Wozniak P.
  • “The Resta Study: A Comparison of Two Preservative-Free Artificial Tears with Sodium Hyaluronate for Relief of Dry Eye.” Labetoulle M.
  • “Visual Outcomes and Rotational Stability Following Implantation of a New Partial Range of Field Toric Enhanced IOL.” Mingo Botin D.
  • “Evaluation of Visual Performance in Patients Implanted with a New Partial Range of Field Enhanced Intraocular Lens.” Castro FJ.
  • “Optical Performance and Refractive Outcomes of a New Monofocal Intraocular Lens with Intermediate Optimized Optics.” Rocha K.
  • “A Non-Interventional, Prospective, Clinical Study of the Performance of an Enhanced Monofocal Intraocular Lens in Patients Undergoing Cataract Surgery: Interim Analysis.” Donnenfeld E.
  • “Retrospective Real-World Evidence Study: User Experience with a Toric and Non-Toric Full Range of Vision Intraocular Lens.” Katz J.
  • “Retrospective Real-World Evidence Study: Performance of a Full Range of Vision, Toric Intraocular Lens in Patients Undergoing Cataract Surgery.” Harasymowycz P.
  • “Improving Cataract Surgery Outcomes Using a Novel IOL Planning Software and Digital Guidance.” Lobanoff M.
  • “Visual Outcomes Following Removal of Corneal Inlay and Implantation of a Small-Aperture Intraocular Lens During Cataract Surgery.” Ang R.
  • “Efficacy and Safety of Excimer Laser Trabeculostomy (ELT), a Laser-Based Trabecular Minimally Invasive Glaucoma Surgery (MIGS) Combined with Phacoemulsification Surgery.” Moreno A.
  • “First Outcomes of Combined Phaco-Emulsification with Excimer Laser Trabeculostomy in Patients with Glaucoma in the Netherlands.” de Crom R.
  • “Visual Performance of Negative Versus Neutral Aspheric Monofocal Intraocular Lenses in Light and Dark Conditions: A Randomized Controlled Trial.” Pantanelli SM.
  • “Evaluation of a Novel Preservative-Free Formulation of Brimonidine Tartrate.” Balidis M.

Posters

  • “Visual Outcomes, Spectacle Independence and Patient-Reported Visual Symptoms Following the Implantation of a New Enhanced Monofocal IOL with Intermediate Optimized Optics.” Mahootchi A.
  • “Early Postoperative 1-Hour Outcomes of a Novel Enhanced Monofocal IOL with Intermediate Optimized Optics Implanted in Patients Undergoing Cataract Surgery.” Stonecipher K.
  • “Real-World Evaluation of the Visual Performance and Patient Satisfaction with a Novel Full Range of Vision Toric Intraocular Lens.” Muzychuk A.
  • “Retrospective Real-World Evidence Study: Performance of a Full Range of Vision, Non-Toric Intraocular Lens in Patients Undergoing Cataract Surgery.” Lobanoff M.
  • “Mesopic Visual Acuity Evaluation After Cataract Surgery in Patients Implanted with a Novel Full Visual Range Intraocular Lens.” Shultz M.
  • “Risk Factors for YAG Capsulotomy Following IC-8 Implantation.” Mehta J.
  • “Bilateral Implantation of the IC-8 Small Aperture IOL in a Post-Radial Keratotomy Patient: A Case Report.” Costantini F.
  • “Clinical Outcomes of the Presbyopic Laser Treatment SUPRACOR in Hyperopic and Myopic Eyes.” Ang R.
  • “Clinical Outcomes of an Excimer Laser Trabecular Bypass Minimally Invasive Glaucoma Surgery Combined with Cataract Surgery in Patients with Primary Open Angle Glaucoma.” Singh P.
  • “Clinical Outcomes of an Excimer Laser Trabecular Bypass Minimally Invasive Glaucoma Surgery Combined with Cataract Surgery in Patients with Ocular Hypertension.” McCabe C.
  • “The Prevalence of Hyperosmolarity and Its Influence on Light Scatter in Patients Undergoing Cataract Surgery.” Nijm L.
  • “A Multi-Country Assessment of Eye Care Professionals’ Perspectives on the Conjunctival Hyperaemia Treatment Landscape.” Ziakas N.

###

About Bausch + Lomb

Our mission is simple – we help people see better to live better, all over the world. For nearly two centuries we’ve evolved with the changing needs of patients and customers, and our commitment to innovation and improving the standard of care in eye health has never been stronger. From contact lenses to prescription products, over-the-counter options, surgical devices and more, we’re turning bold ideas into better outcomes through passion, perseverance and purpose. Learn more at www.bausch.com and connect with us on Facebook , Instagram , LinkedIn , X and YouTube .

 



Media Contact:

Caryn Marshall

[email protected]

(908) 493-1381

© 2025 Bausch + Lomb.

ORIGINAL
Back to Press Releases